NCT03645928 2025-06-19Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsIovance Biotherapeutics, Inc.Phase 2 Recruiting245 enrolled
NCT06101134 2025-04-14A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose CombinationsBristol-Myers SquibbPhase 2 Active not recruiting100 enrolled